Delivery Order SPE2DB22D2206-SPE2DB24FGN74
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,989.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ORGOVYX 120 MG TABLET UU 30S pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ORGOVYX 120 MG TABLET UU 30S. This $1,329.89 award, with a completion date of February 22, 2024, is part of Amerisourcebergen Drug Corp's role as the prime contractor on an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- The U.S. Defense Logistics Agency (DLA) has awarded a $1,329.89 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORGOVYX 120 MG TABLET. This contract has an ultimate completion date of September 27, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical...
- This is a $1,329.89 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S, with an ultimate completion date of September 24, 2024. The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ORGOVYX 120 MG TABLET medical supplies. The contract has a ceiling value of $2,659.78 and a performance period through May 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to supply a range of pharmaceutical products and medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,329.89 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,385.52 firm fixed price delivery order is for the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. The contract has an ultimate completion date of August 7, 2025. Amerisourcebergen Drug Corp is the prime contractor and the contract is not set-aside. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ORGOVYX 120 MG TABLET UU 30S. This $7,979.34 order has a completion date of March 11, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds a broader indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply ORGOVYX 120 MG TABLET pharmaceuticals. The $7,979.34 contract has a performance period ending on March 28, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this delivery order, which is issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $3,989.67 worth of ORGOVYX 120 MG TABLET medical products. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and provides a wide range of pharmaceutical products and medical supplies to...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGN74Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,329.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp that has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order has an ultimate completion date of April 29, 2024. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/8/24 |